Correction to COBALT: A Confirmatory Trial of Obeticholic Acid in Primary Biliary Cholangitis With Placebo and External Controls

Kris V. Kowdley, Gideon M. Hirschfield, Charles Coombs, Elizabeth S. Malecha, Leona Bessonova, Jing Li, Nuvan Rathnayaka, George Mells, David E. Jones, Palak J. Trivedi, Bettina E. Hansen, Rachel Smith, James Wason, Shaun Hiu, Dorcas N. Kareithi, Andrew L. Mason, Christopher L. Bowlus, Kate Muller, Marco Carbone, Marina BerenguerPiotr Milkiewicz, Femi Adekunle, Alejandra Villamil

Research output: Contribution to journalComment/debate

1 Citation (Scopus)

Abstract

In the original text, there is a typographical error in the first paragraph of the Results section. The sentence “At that time, 631 patients had been screened, with 434 patients randomized…” was incorrect. The corrected text is: “At that time, 631 patients had been screened, with 334 patients randomized…”

This has been corrected in the online version of the article.
Original languageEnglish
Pages (from-to)263
Number of pages1
JournalThe American journal of gastroenterology
Volume120
Issue number1
DOIs
Publication statusPublished - Jan 2025
Externally publishedYes

Keywords

  • confounding variables
  • functional unblinding
  • inverse probability of censoring weighting
  • treatment crossover

Fingerprint

Dive into the research topics of 'Correction to COBALT: A Confirmatory Trial of Obeticholic Acid in Primary Biliary Cholangitis With Placebo and External Controls'. Together they form a unique fingerprint.

Cite this